Grown Rogue International (GRUSF) Interest Coverage Ratio (QoQ) (2012 - 2026)
Grown Rogue International (GRUSF) Interest Coverage Ratio (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 757.41% |
| Mar 31, 2026 | -96.38% |
| Dec 31, 2025 | 222.31% |
| Sep 30, 2025 | -100.00% |
| Jun 30, 2025 | 92,671,031,272,848.20% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 84.50% |
| Oct 31, 2023 | -24.24% |
| Jul 31, 2023 | 44.40% |
| Apr 30, 2023 | -35.22% |
| Jul 31, 2021 | -185.53% |
| Apr 30, 2021 | -85.20% |
| Jan 31, 2021 | 57,380.18% |
| Oct 31, 2020 | -102.81% |
| Jul 31, 2020 | -14.54% |
| Apr 30, 2020 | 526.05% |
| Jan 31, 2020 | 85.71% |
| Oct 31, 2019 | 4.82% |
| Jul 31, 2019 | 90.58% |
| Apr 30, 2019 | -645.05% |